- CA$39.97m
- CA$38.84m
- CA$28.86m
Brief: Medicure Posts Qtrly Earnings Per Share $0.11
Brief: Medicure Reports Financial Results For Quarter Ended June 30, 2022
Brief: Medicure Announces Resignation Of CFO And Succession Plan
Brief: Algernon Pharmaceuticals Appoints James Kinley As CFO Effective From December 1, 2021
Brief: Medicure Inc - QTRLY Total Net Revenue From Sale Of Products Of $4.9 Million
Brief: Medicure Reports Quarterly Loss Per Share Of $0.09
Brief: Medicure Inc Says Planning To Launch National Direct-To-Consumer E-Commerce Pharmacy Platform Through Its Unit, Marley Drug Pharmacy, Before End Of 2021
Brief: Medicure Updates On Percutaneous Coronary Intervention Study
Brief: Medicure Appoints David Gurvey As CFO
Brief: Medicure Quarterly Loss Per Share C$0.10
Brief: Medicure CFO James Kinley Resigns
Brief: Medicure Reports Qtrly Loss Per Share $0.41
Brief: Medicure Announces Pivotal Phase 3 Trial IND Filing With FDA For Treatment Of Seizures Associated With PNPO Deficiency
Brief: Medicure To Acquire 100% Of Marley Drug Inc
Brief: Medicure Announces Settlement of Patent Infringement Action
Brief: Medicure Reports Qtrly Total Net Rev From Sale Of Products Of $3.5 Mln
Brief: Medicure Enters Into Agreement With Reliance Life Sciences
Brief: Medicure Announces AGGRASTAT Shows Promise In Treating Thrombotic Complications Due To COVID-19
Brief: Medicure Announces Termination Of ReDS Pro Marketing And Distribution Agreement